X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6630) 6630
Newsletter (569) 569
Publication (523) 523
Book Review (69) 69
Magazine Article (31) 31
Newspaper Article (16) 16
Book Chapter (13) 13
Dissertation (10) 10
Conference Proceeding (5) 5
Reference (4) 4
Trade Publication Article (4) 4
Book / eBook (3) 3
Government Document (3) 3
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fluoxetine (4989) 4989
male (3541) 3541
humans (3147) 3147
animals (2521) 2521
psychiatry (2400) 2400
female (2313) 2313
pharmacology & pharmacy (2067) 2067
index medicus (2047) 2047
neurosciences (1783) 1783
rats (1615) 1615
adult (1602) 1602
antidepressants (1567) 1567
fluoxetine - pharmacology (1560) 1560
depression (1302) 1302
fluoxetine - administration & dosage (1270) 1270
serotonin (1227) 1227
fluoxetine - therapeutic use (1115) 1115
middle aged (1088) 1088
dose-response relationship, drug (964) 964
treatment outcome (930) 930
mice (903) 903
serotonin uptake inhibitors - pharmacology (901) 901
serotonin uptake inhibitors - therapeutic use (867) 867
depressive disorder - drug therapy (818) 818
research (816) 816
serotonin uptake inhibitors - administration & dosage (800) 800
depression, mental (796) 796
drug administration schedule (759) 759
major depression (742) 742
double-blind (689) 689
clinical neurology (665) 665
fluoxetine - adverse effects (650) 650
adolescent (638) 638
rats, sprague-dawley (624) 624
brain (615) 615
double-blind method (614) 614
drug therapy (611) 611
antidepressive agents - therapeutic use (589) 589
antidepressive agents - pharmacology (570) 570
antidepressant (568) 568
serotonin uptake inhibitors - adverse effects (549) 549
dosage and administration (545) 545
time factors (539) 539
aged (524) 524
drug therapy, combination (524) 524
depression - drug therapy (521) 521
serotonin reuptake inhibitors (514) 514
drugs (503) 503
anxiety (499) 499
analysis (487) 487
paroxetine (482) 482
rats, wistar (473) 473
behavior, animal - drug effects (459) 459
disease models, animal (457) 457
depressive disorder, major - drug therapy (455) 455
antidepressive agents - administration & dosage (451) 451
sertraline (443) 443
serotonin - metabolism (425) 425
care and treatment (410) 410
serotonin uptake inhibitors (408) 408
major depressive disorder (397) 397
drug interactions (396) 396
psychiatric status rating scales (388) 388
mental depression (385) 385
depressive disorder - psychology (377) 377
efficacy (356) 356
hippocampus (356) 356
health aspects (351) 351
antidepressive agents, second-generation - therapeutic use (336) 336
brain - drug effects (335) 335
psychology, clinical (333) 333
motor activity - drug effects (325) 325
stress (323) 323
antidepressive agents, second-generation - administration & dosage (322) 322
brain - metabolism (312) 312
hippocampus - drug effects (307) 307
article (303) 303
behavior (303) 303
imipramine (301) 301
rat (296) 296
rodents (295) 295
child (293) 293
placebo (288) 288
antidepressive agents - adverse effects (284) 284
receptors (275) 275
citalopram (274) 274
rat-brain (274) 274
risk factors (274) 274
analysis of variance (260) 260
obsessive-compulsive disorder (260) 260
antidepressive agents, second-generation - pharmacology (253) 253
dopamine (252) 252
behavioral sciences (251) 251
pharmacology (247) 247
antidepressive agents, second-generation - adverse effects (246) 246
reports (245) 245
placebo-controlled trial (244) 244
children (241) 241
forced swimming test (238) 238
physiological aspects (235) 235
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (2) 2
OISE - May be requested in 6-10 wks (1) 1
OISE - Theses (1) 1
Online Resources - Online (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7121) 7121
French (33) 33
Russian (26) 26
Spanish (22) 22
German (19) 19
Chinese (14) 14
Polish (8) 8
Danish (5) 5
Japanese (4) 4
Norwegian (4) 4
Portuguese (4) 4
Dutch (3) 3
Italian (3) 3
Turkish (3) 3
Finnish (2) 2
Korean (2) 2
Persian (2) 2
Swedish (2) 2
Arabic (1) 1
Hebrew (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Serotonin (5-HT) is a neurotransmitter that is involved in many behavioral functions, including the organization of defense, and its putative pathological... 
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | 5-HYDROXYTRYPTAMINE RELEASE | RAT | 5-HT1A RECEPTOR ANTAGONISTS | REUPTAKE INHIBITORS | DORSAL RAPHE | ADULT ZEBRAFISH | ELEVATED PLUS-MAZE | T-MAZE | NEUROSCIENCES | IN-VIVO | PHARMACOLOGY & PHARMACY | BRAIN | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine
Journal Article
Pediatrics, ISSN 0031-4005, 05/2011, Volume 127, Issue 5, pp. e1312 - e1321
CONTEXT: As many as 1 in every 110 children in the United States has an autism spectrum disorder (ASD). Many medical treatments for ASDs have been proposed and... 
Autism spectrum disorders | Antipsychotics | Fluoxetine | Serotonin-reuptake inhibitors | Aripiprazole | Risperidone | Citalopram | Psychostimulants | psychostimulants | MANAGEMENT | HYPERACTIVITY | risperidone | SYMPTOMS | PERVASIVE DEVELOPMENTAL DISORDERS | fluoxetine | serotonin-reuptake inhibitors | COGNITIVE-BEHAVIORAL THERAPY | ADOLESCENTS | antipsychotics | DOUBLE-BLIND | aripiprazole | PEDIATRICS | autism spectrum disorders | RETROSPECTIVE ANALYSIS | citalopram | Piperazines - administration & dosage | Serotonin Antagonists - administration & dosage | Prognosis | Antipsychotic Agents - adverse effects | Humans | Citalopram - adverse effects | Child, Preschool | Male | Child Development Disorders, Pervasive - drug therapy | Dose-Response Relationship, Drug | Quinolones - adverse effects | Serotonin Antagonists - adverse effects | Child Development Disorders, Pervasive - diagnosis | Risperidone - adverse effects | Female | Child | Fluoxetine - adverse effects | Severity of Illness Index | Drug Administration Schedule | Risperidone - administration & dosage | Treatment Outcome | Evidence-Based Medicine | Piperazines - adverse effects | Randomized Controlled Trials as Topic | Antipsychotic Agents - administration & dosage | Quinolones - administration & dosage | Citalopram - administration & dosage | Fluoxetine - administration & dosage | Patient Compliance | Autism | Care and treatment | Dosage and administration | Antipsychotic drugs | Research | Studies | Pediatrics | Systematic review | Medical treatment | Childrens health
Journal Article
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Research
Journal Article
Neuroscience Letters, ISSN 0304-3940, 11/2017, Volume 660, pp. 79 - 85
Journal Article
Journal Article
Trials, ISSN 1745-6215, 01/2019, Volume 20, Issue 1, pp. 34 - 11
BackgroundMajor depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50-75% of patients have a treatment... 
Phosphocreatine | Fluoxetine | Randomized controlled trial | Adenosine triphosphate | Fast-acting antidepressant | Major depressive disorder | MEDICINE, RESEARCH & EXPERIMENTAL | CREATINE MONOHYDRATE AUGMENTATION | ENERGY | EFFICACY | SERTRALINE | PREFRONTAL CORTEX | DAMAGE | WOMEN | METABOLISM | HYPOTHESIS | COENZYME-Q10 | Adenosine Triphosphate - administration & dosage | Antidepressive Agents, Second-Generation - adverse effects | Humans | Middle Aged | Male | Antidepressive Agents, Second-Generation - administration & dosage | Feasibility Studies | Young Adult | Time Factors | China | Adult | Female | Drug Therapy, Combination | Fluoxetine - adverse effects | Adenosine Triphosphate - adverse effects | Depressive Disorder, Major - drug therapy | Affect - drug effects | Patient Health Questionnaire | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Serotonin Uptake Inhibitors - adverse effects | Treatment Outcome | Phosphocreatine - adverse effects | Phosphocreatine - administration & dosage | Randomized Controlled Trials as Topic | Depressive Disorder, Major - psychology | Administration, Intravenous | Pilot Projects | Serotonin Uptake Inhibitors - administration & dosage | Adolescent | Fluoxetine - administration & dosage | Aged | Depressive Disorder, Major - diagnosis | Usage | Physiological aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Health aspects | Testing
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 06/2011, Volume 36, Issue 7, pp. 1518 - 1530
Journal Article
Brain Behavior and Immunity, ISSN 0889-1591, 07/2013, Volume 31, pp. 96 - 104
► Repeated and intermittent LPS injections to female mice is a useful model of chronic depression; treatment with fluoxetine for 3 weeks abolishes the... 
Chronic depression | Oxidative and nitrosative stress | Inflammation | Cytokines | LPS | Leaky gut | Fluoxetine | Mitogens | Analysis | Depression, Mental
Journal Article
Psychopharmacologia, ISSN 0033-3158, 2011, Volume 217, Issue 3, pp. 419 - 432
Journal Article